US 8530492
Oligomer-protein tyrosine kinase inhibitor conjugates
granted A61KA61K31/506A61K47/60
Quick answer
US patent 8530492 (Oligomer-protein tyrosine kinase inhibitor conjugates) held by Nektar Therapeutics expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/506, A61K47/60, A61P, A61P35/00